| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/21/2009 | US20090130093 Binding member for gm-csf receptor |
| 05/21/2009 | US20090130078 Treatment for Cardiovascular Disease |
| 05/21/2009 | US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/21/2009 | US20090130021 Methods, products and uses involving platelets and/or the vasculature |
| 05/20/2009 | EP2060300A1 C-19 steroids for therapeutic uses |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP2060265A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/20/2009 | EP2060263A1 Lipid-metabolism-ameliorating agent |
| 05/20/2009 | EP2060256A1 Pharmaceutical and nutraceutical compositions based on menaquinols |
| 05/20/2009 | EP2059520A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 05/20/2009 | EP2059519A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/20/2009 | EP2059508A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 05/20/2009 | EP2059246A2 Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor |
| 05/20/2009 | EP2059241A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 05/20/2009 | EP2059240A1 Novel composition and method effective in inhibiting the atherogenic process |
| 05/20/2009 | EP2059138A1 Polyphenol extraction process |
| 05/20/2009 | EP2059136A1 Apples with high polyphenolic content |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1354888B1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007055007A1 Verfahren zur Übertragung und Konservierung von Aroma- und Inhaltsstoffen von Pflanzen und/oder Pflanzenteilen auf eine ölhaltige Basissubstanz, angereicherte Basissubstanz und deren Verwendungen Method for transmitting and preserving and flavoring ingredients of plant and / or plant parts to a base substance containing oil-enriched base substance and uses thereof |
| 05/20/2009 | DE102007054877A1 Use of hyaluronidase e.g. as a drug for the treatment of profibrotic metabolic disorder, fibrotic liver disease, chronic viral liver disease, portal hypertension, chronic hepatitis C and hepatocellular carcinoma |
| 05/20/2009 | DE102007054786A1 Trisubstituierte Furopyrimidine und ihre Verwendung Trisubstituted Furopyrimidine and their use |
| 05/20/2009 | CN101437942A Pharmaceutical compositions comprising anti-miRNA antisense oligonucleotides |
| 05/20/2009 | CN101437818A Novel dual action receptors antagonists (DARA) at the AT1 and ETA receptors |
| 05/20/2009 | CN101437804A Dibenzyl amine compounds and derivatives |
| 05/20/2009 | CN101437576A Treatment of peripheral vascular disease using postpartum-derived cells |
| 05/20/2009 | CN101437521A Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament |
| 05/20/2009 | CN101437508A Stearidonic acid for improving cardiovascular health |
| 05/20/2009 | CN101434660A Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 05/20/2009 | CN101434593A Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/20/2009 | CN101434580A Mesaconitine acylated product nitrous oxide, preparation and use |
| 05/20/2009 | CN101434579A Fuziline esterification derivative, synthetic method and use |
| 05/20/2009 | CN101433717A Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433699A Granular formulation for treating hypertension and hyperlipemia, and preparation method thereof |
| 05/20/2009 | CN101433689A Kudzu root and longstamen onion bulb oral liquid and preparation method |
| 05/20/2009 | CN101433676A Chinese medicinal composition with function for reducing blood pressure and preparation method thereof |
| 05/20/2009 | CN101433675A Capsule for treating cerebral infarction |
| 05/20/2009 | CN101433674A Medicament for treating cardiovascular disease |
| 05/20/2009 | CN101433640A Haemostatic medicament for hemorrhoid and preparation method thereof |
| 05/20/2009 | CN101433624A Lipid-lowering pressure-releasing hypoglycemic medicament and preparation method thereof |
| 05/20/2009 | CN101433610A Shan ju coated dispersible tablet for releasing pressure and preparation method thereof |
| 05/20/2009 | CN101433586A Medicament for treating ischemic cerebrovascular disease and preparation method thereof |
| 05/20/2009 | CN101433584A Pharmaceutical composition for treating qi deficiency and blood stasis type coronary heart disease and preparation method thereof |
| 05/20/2009 | CN101433583A Salvia root composition and preparation thereof, and detecting method and use |
| 05/20/2009 | CN101433581A Pharmaceutical composition |
| 05/20/2009 | CN101433567A Clinical novel use of soft capsule for removing thromboembolism |
| 05/20/2009 | CN101433554A Externally appiled powdered Chinese medicine for treating angiitis and preparation method thereof |
| 05/20/2009 | CN101433553A Method for preparing deproteinized extract of calf blood and freeze-dried powder thereof |
| 05/20/2009 | CN101433539A Therapeutic compositions containing amlodipine niacin and rosuvastatin medicament |
| 05/20/2009 | CN101433538A Therapeutic compositions containing amlodipine and niacin medicament |
| 05/20/2009 | CN101433536A Therapeutic compositions containing amlodipine niacin and losartan medicament |
| 05/20/2009 | CN101433528A Method for preparing stable water dispersion xanthophyll microcapsule from xanthophyll crystal |
| 05/20/2009 | CN101433523A Breviscapine freeze-dry orally disintegrating tablets and preparation method thereof |
| 05/20/2009 | CN101433508A Foot bath composition for reducing blood pressure |
| 05/20/2009 | CN100488964C N2-arylformyl-4-ammonia/amidopteridine compound capable of regulating nitrous oxide synthase acitivity |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488947C Serine protease inhibitors |
| 05/20/2009 | CN100488946C Salts of guanidine derivatives and its pharmaceutical preparations composition |
| 05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
| 05/20/2009 | CN100488513C Medicine for treating cerebrovascular and cardiovascular diseases and preparation process thereof |
| 05/20/2009 | CN100488508C Pharmaceutical composition containing tetrahydroisoquinoline compounds |
| 05/20/2009 | CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 05/20/2009 | CN100488503C Pharmaceutical composition for treating cardiovascular and cerebrovascular disease |
| 05/20/2009 | CN100488501C Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyper-permeability or undesired permeability |
| 05/20/2009 | CN100488499C Orally disintegrating tablet of coenzyme Q10 and preparation method thereof |
| 05/20/2009 | CN100488497C Use of leukotriene in preparing medicament |
| 05/19/2009 | US7534887 Thiazoline derivative and use of the same |
| 05/19/2009 | US7534815 Preventive or remedy for hypertension |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534456 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity |
| 05/19/2009 | CA2591917C Analgesic compositions for treating painful conditions of the anal region and uses thereof |
| 05/19/2009 | CA2468879C Substituted cyclohexane derivatives |
| 05/19/2009 | CA2407929C Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2375017C Hydrochloride of fused-heterocycle compound |
| 05/19/2009 | CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/19/2009 | CA2364801C Pyridazin-3-one derivatives and medicines containing the same |
| 05/19/2009 | CA2292968C Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061889A2 Grape polyphenolics for platelet and bacterial control |
| 05/14/2009 | WO2009061852A2 Modulation of factor 9 expression |
| 05/14/2009 | WO2009061851A2 Modulation of factor 7 expression |
| 05/14/2009 | WO2009061830A1 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor |
| 05/14/2009 | WO2009061807A2 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 05/14/2009 | WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 05/14/2009 | WO2009061445A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/14/2009 | WO2009060952A1 Novel preparation |
| 05/14/2009 | WO2009060621A1 Medical composition for preventing post-surgical adhesion |
| 05/14/2009 | WO2009060608A1 Sustained release composition containing sdf-1 |
| 05/14/2009 | WO2009040083A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040047A3 Therapeutic uses of ghrelin and combinations with stresscopin |
| 05/14/2009 | WO2009040033A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040019A3 Use of a peptide as a therapeutic agent |